diisopropyl 1,3-dithiol-2-ylidenemalonate has been researched along with Liver Cirrhosis, Biliary in 1 studies
diisopropyl 1,3-dithiol-2-ylidenemalonate: structure in first source
Liver Cirrhosis, Biliary: FIBROSIS of the hepatic parenchyma due to obstruction of BILE flow (CHOLESTASIS) in the intrahepatic or extrahepatic bile ducts (BILE DUCTS, INTRAHEPATIC; BILE DUCTS, EXTRAHEPATIC). Primary biliary cholangitis involves the destruction of small intra-hepatic bile ducts and decreased bile secretion. Secondary biliary cholangitis is produced by prolonged obstruction of large intrahepatic or extrahepatic bile ducts from a variety of causes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
1 trial available for diisopropyl 1,3-dithiol-2-ylidenemalonate and Liver Cirrhosis, Biliary
| Article | Year |
|---|---|
The results of a randomized double blind controlled trial evaluating malotilate in primary biliary cirrhosis. A European multicentre study group.
Topics: Adult; Double-Blind Method; Europe; Female; Follow-Up Studies; Humans; Liver Cirrhosis, Biliary; Mal | 1993 |